Conducted

November 10, 2020

5675 US adults surveyed

Share

Pfizer announced that an early analysis of its COVID‑19 vaccine trial suggested it was 90% effective in preventing the disease. It may begin manufacturing millions of vaccine doses this year. How much credit, if any, do you believe President Donald Trump should receive for the vaccine's possible readiness?

Conducted November 10, 2020

YouGov surveyed 5675 US adults

25%
14%
15%
37%
10%
Pfizer announced that an early analysis of its COVID‑19 vaccine trial suggested it was 90% effective in preventing the disease. It may begin manufacturing millions of vaccine doses this year. How much credit, if any, do you believe President Donald Trump should receive for the vaccine's possible readiness?

Conducted November 10, 2020

YouGov surveyed 5675 US adults

By:
25%
14%
15%
37%
10%

Explore more data & articles

Published on the same day

How much, if at all, would you trust a COVID-19 vaccine from the drug maker Pfizer?

See results

Do you think the country will become more united or more divided once Joe Biden is in office, or will there be no change?

See results

Most Americans believe marijuana is safer than alcohol and tobacco

Health

Half of Americans expect to view the April 8 solar eclipse

Health

What do Americans think about scientists?

Health

What do Americans want in a primary care provider? An honest practitioner who takes their insurance

Health

Americans with higher incomes are more likely to have straight, white teeth

Health

What Americans think about boundaries and romantic relationships

Health

Views on COVID-19 and vaccines remain divided by party

Health

Many Americans link increases in extreme weather to climate change

Health

One in four Americans say there is currently a COVID-19 pandemic

Health